Cargando…
G-Force PD: a global initiative in coordinating stem cell-based dopamine treatments for Parkinson’s disease
Translating new cell-based therapies to the clinic for patients with neurodegenerative disorders is complex. It involves pre-clinical testing of the cellular product and discussions with several regulatory agencies, as well as ethical debates. In an attempt to support efforts around the world, we se...
Autores principales: | Barker, Roger A, Studer, Lorenz, Cattaneo, Elena, Takahashi, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516551/ https://www.ncbi.nlm.nih.gov/pubmed/28725685 http://dx.doi.org/10.1038/npjparkd.2015.17 |
Ejemplares similares
-
GFORCE-PD still going strong in 2016
por: Parmar, Malin, et al.
Publicado: (2017) -
Vibrotactile coordinated reset stimulation for the treatment of Parkinson's disease
por: Tass, Peter A.
Publicado: (2021) -
Compare and contrast the reaction coordinate diagrams for chemical reactions and cytoskeletal force generators
por: Scholey, Jonathan M.
Publicado: (2013) -
Dopamine regulation of striatal inhibitory transmission and plasticity: dopamine, low or high?
por: Hernández-Echeagaray, Elizabeth
Publicado: (2016) -
Adenosine A(2A)-dopamine D(2) receptor heteromers operate striatal function: impact on Parkinson's disease pharmacotherapeutics
por: Fernández-Dueñas, Víctor, et al.
Publicado: (2018)